Carbamazepine
- Product NDC
- 70518-2653
- 11-digit product format
- 705182653
- Labeler code
- 70518
- Product ID
- 70518-2653_cc6fee50-0343-92d5-e053-2a95a90a6f4d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Carbamazepine
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- NDA020234
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2020-03-25
- Marketing end
- 0000-00-00
- Substance
- CARBAMAZEPINE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2653-0 | 70518265300 | 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-2653-0) | 2020-03-25 | 0000-00-00 | No | No | Current |